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Abstract: Several of most common dermatoses worldwide, e.g., psoriasis and atopic dermatitis,
are worsened in their clinical picture when the skin is regularly exposed to an increased air pollution
level, e.g., particulate matter. This is explainable by the activation of the aryl hydrocarbon receptor
(AhR) in the skin, which results in an increased release of proinflammatory cytokines and matrix
metalloproteinases. Symurban is a competitive AhR antagonist and thus allows the effective protection
of skin. In order to improve its dermal bioavailability as a poorly soluble active agent (0.25 µg/mL),
nanocrystals were prepared and evaluated. Nanocrystals are pure active crystals reduced in particle
size to the submicron range of 100 to 1000 nm. They feature the properties of nanocrystals, such as
increased saturation solubility and dissolution velocity, without having to be declared as nanomaterial.
Production methods and parameters were systematically investigated. Wet bead milling at 2000 rpm
for 30 min yielded the best results. A z-average of 280 nm was achieved for a 10% Symurban suspension
with a polydispersity index of 0.20, indicating a narrow size distribution. For the long-term stabilization
of the nanocrystal suspension, the performance of 15 surfactants of different categories and HLB
values were investigated and evaluated. It was found that non-ionic surfactants in general were
better able to stabilize the system than anionic or amphoteric surfactants. Highest stability of over 12
months at 25 ◦C was achieved with 2% Plantacare 810 UP, an ECOCERT surfactant with high skin
tolerance. The suspension was also chemically long-term stable with >97% of remaining Symurban
over 12 months. The saturation solubility of Symurban as nanocrystals was significantly increased
from 0.25 to 2.9 µg/mL, which corresponds to a factor of >11. In a case study of one male volunteer
with healthy skin conditions, penetration profiles of Symurban nanocrystal hydrogel and commercial
anti-pollution serum containing an identical amount of Symurban were determined and compared.
After 20 min of exposure, the relative Symurban concentration in the deeper skin layers (tape 19-30)
was more than two times higher for nanocrystal hydrogel (16%) than the commercial serum (7%).
These results suggest that nanocrystals are a promising delivery system for the poorly soluble
anti-pollution agent Symurban.
Keywords: benzylidene dimethoxydimethylindanone; competitive inhibitor of aryl hydrocarbon receptor;
high pressure homogenization; wet bead milling; nanosuspension; gas chromatography–mass spectrometry;
saturation solubility; skin penetration
1. Introduction
As a result of worldwide urbanization, the quality of air is constantly declining. According to
the World Health Organization (WHO), 91% of urban population is exposed to air quality exceeding
the limit of health concern [1]. A correlation between air quality and diseases affecting the lungs
and cardiovascular systems has already been proven with 29% of lung cancer, 25% of heart diseases,
and 43% of lung diseases attributed to air pollution in 2016 [1]. In recent years, increasingly the effect
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of air pollution on the largest organ exposed to the environment, the skin, has been studied [2–4].
Air pollution is defined as the contamination of the environment by any agent that modifies the natural
characteristics of the atmosphere. According to the WHO, pollutants of major public health concern
include particulate matter, carbon monoxide, ozone, nitrogen dioxide and sulfur dioxide [1]. It was
found that in particular, the exposure of the skin to polycyclic aromatic hydrocarbons (PAHs) and
halogenated aromatic hydrocarbons (HAHs) is harmful. They originate from incomplete burning of
organic material and are primarily present in industrial exhaust gases, fuel burning, cigarette smoke,
etc., and are transported by airborne fine dust particles [5]. Penetrating into skin, the transcription factor
aryl hydrocarbon receptor (AhR) is specifically activated [6–9], resulting in the upregulation of various
pharmacological processes, e.g., enzymes of the cytochrome P450 family [10], melanogenesis [11],
cellular oxidant/antioxidant regulation [12], immune regulation [13–15] and regulation of the epidermal
barrier function [16] (Figure 1). From this, the pathogenesis of various skin diseases is stimulated, such
as vitiligo [17], psoriasis [18,19] scleroderma [20], neurodermatitis [21], and acne vulgaris [22]. Further,
the promotion of dermal carcinogenesis is discussed in following references [23–25].
Figure 1. Schematic illustration of impacts on skin caused by polycyclic aromatic hydrocarbons (PAHs)
and hydrogenated aromatic hydrocarbons (HAHs) adherent to the surface of particulate matter (PM),
and UV-light exposure.
The concern about skin damage caused by air pollution is particularly evident in the personal
care segment, where in 2016, 79% of all products marketed worldwide had an anti-pollution claim [26].
In the same year, Symurban (INCI: Benzylidene Dimethoxydimethylindanone) was introduced to
the market by the company Symrise as an anti-pollution active agent. As a competitive inhibitor
of AhR, Symurban inhibits PAH/HAH-induced effects [27–29]. However, its low solubility results
in low penetration. One physical approach for increasing its saturation solubility and thereby its
dermal bioavailability is the formation of nanocrystals [30–34]. By the reduction of particle size from
the µm-range to the nm-range, a significantly increased saturation solubility [34–37] and a higher
dissolution rate [30,37,38] can be achieved. As a result, a greater concentration gradient is created
between the formulation and the skin, enhancing the passive diffusion of the active ingredient into the
skin. Due to the increased dissolution rate, the penetrated active agent molecules can then be quickly
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replaced, and the high concentration gradient can be maintained over a long period of time. To avoid
consumer concerns about nanoproducts, the size of the particles can be adjusted to the so-called
submicron range of 100–1000 nm. They still have the properties of nanocrystals, but do not have to be
declared as nanomaterials, since according to the EU regulation, a product only has to be labelled as
nano if more than 50% of the particles have a diameter of <100 nm [39].
Therefore, the aim of this work was to apply nanocrystal technology on Symurban to increase
its solubility and thereby its skin penetration in order to obtain the full potency of Symurban as
an anti-pollution agent in vivo.
2. Materials and Methods
2.1. Materials
All materials used in this work are listed in Table 1, including trade name, INCI name and
manufacturer/distributor. Milli-Q water was freshly produced using a Milli-Q system from Millipore
GmbH (Darmstadt, Germany).
Table 1. Overview of all materials used in this work.






Dimethoxydimethylindanone Symrise AG, Germany
Amphoterge® W-2 Disodium Cocoamphoacetate
Lonza Group AG,
Switzerland
Bergasoft SCG 22 Sodium Cocoyl Glycinate Berg + Schmidt GmbH & Co.KG, Germany
Dermofeel® G10L Polyglyceryl-10 Laurate
Evonik Dr. Straetmans
GmbH, Germany
Eumulgin® SG Sodium Stearoyl Glutamate BASF SE, Germany
Kolliphor® P407 Poloxamer 407 BASF SE, Germany
Lanette® E Cetaryl sulphate BASF SE, Germany
Miranol® Ultra C32 Sodium Cocoamphoacetate Solvay, Belgium
Plantacare® 2000 UP Decyl-Glucoside BASF SE, Germany
Plantacare® 810 UP Coco-Glucoside BASF SE, Germany
Polyaldo® 10-1-CC Polyglyceryl-10 Caprylate/Caprate
Lonza Group AG,
Switzerland
Sisterna® L70-C Sucrose Alkyl Ester Sisterna B.V., Netherlands
Sisterna® SP70-C Sucrose Alkyl Ester Sisterna B.V., Netherlands


































Alphagaz™ 1 He Helium 99,999% AIR LIQUIDE DeutschlandGmbH, Germany
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2.2. Production of Symurban Nanocrystals
2.2.1. High-Pressure Homogenization
Symurban (10 wt%), Polysorbate 80 (2 wt%) and double-distilled water (88 wt%) were
pre-homogenized using a rotor-stator-homogenizer (Ultra-Turrax T25, IKA-Werke GmbH & Co.
KG, Staufen im Breisgau, Germany) at 8500 rpm for 60 seconds. The obtained pre-suspension
was subsequently high-pressure homogenized (Micron LAB 40, APV Gaulin GmbH, Langenhagen,
Germany) in 3 steps—2 cycles at 500 bar, 2 cycles at 1000 bar and 15 cycles at 1500 bar. High-pressure
homogenization is a high-energy process that leads to a temperature increase of the sample above
room temperature during production. When the sample cools down to room temperature again after
production, the system is supersaturated and Ostwald ripening occurs. To avoid this, the production
temperature was set to 5 ◦C.
2.2.2. Bead Milling
Symurban (10 wt%), Polysorbate 80 (2 wt%) and double-distilled water (88 wt%) were milled in
a PML-2 pearl mill (Bühler AG, Uzwil, Switzerland) using SiLibeads type ZY-E 0.4–0.6 mm (Sigmund
Lindner GmbH, Warmensteinach, Germany). Milling time was set to 30 min, the rotation speed to
2000 rpm and the temperature, here also, at 5 ◦C. After comparing both methods for their suitability to
produce Symurban nanocrystals using the surfactant Polysorbate 80 as standard, a detailed surfactant
screening (c.f. Table 1 of Section 2.1.) was subsequently carried out on the bead mill. Therefore,
Symurban (10 wt%), on 15 selected surfactants (2 wt%) and double-distilled water (88 wt%), was milled
for 20 min at a rotation speed of 2000 rpm and 5 ◦C.
2.3. Particle Characterization
2.3.1. Photon Correlation Spectroscopy (PCS)
The mean particle diameter and polydispersity index (PdI) of prepared nanocrystals were
determined by dynamic light scattering using a Zetasizer Nano ZS (Malvern Instruments,
Worcestershire, UK). Before measurement, the samples were diluted 1:1000 (vol%) in Milli-Q-water.
Each sample was measured 10 times and the average was calculated and reported as a z-average
(z-ave).
2.3.2. Laser Diffraction (LD)
The volume-weighted particle diameter and distribution were measured by laser diffraction
using a Mastersizer 2000 equipped with a Hydro 2000S dispersing unit (both Malvern Instruments,
Worcestershire, UK). The refractive index used for Symurban was 1.610, which was determined prior to
LD measurement. As imaginary refractive index 0.100 was used. Sample was added to the dispersion
unit until a laser obscuration between 4–6% was reached. Stirring speed was set to 1750 rpm. Loose
aggregates, if present, were re-dispersed by ultrasound at 25% to 75%.
2.3.3. Light Microscopy
Samples were additionally examined by light microscopy using BA 210 (Motic Deutschland
GmbH, Wetzlar, Germany) at 100-, 400-, and 1000-times magnification to detect possible particles and
aggregates in µm-size.
2.3.4. Zeta Potential
The surface charge of prepared nanocrystals was determined using the Zetasizer Nano ZS again
(c.f. 2.3.1). Prior to measurement, the sample was diluted 1:100 (vol%) with conductivity-adjusted
water (to 50 µS/cm with NaCl) at 20 ◦C. One sample was measured in triplicate and the calculated
mean value was used as the result.
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2.4. Gas Chromatography–Mass Spectrometry (GC-MS)
The Symurban concentration was determined to assess the chemical stability, saturation solubility
and the penetration of Symurban nanocrystals. Therefore, GC-MS analysis was carried out using
an Agilent Technologies 7890A GC System paired with an Agilent Technologies 5975C quadrupole
MS-detector. As a column, an Agilent J&W GC column type 122–5532 G was used. At a heating rate of
20 K/min, the temperature was raised from 120 to 320 ◦C and maintained for 5 min. The flow rate of
helium in the mobile phase was set to 1 mL/min. For the measurement, 2 µL of sample was injected with
a split ratio of 1:10. The detector was used in SIM-mode at a molar mass of 293 M, being the main peak
of mono-demethylated Symurban derivative, formed due to electron impact ionization. Symurban as
the E and Z isomer was detected at the retention times of 11.6 and 11.8 min, respectively. The total
amount of Symurban was calculated as the sum of the two peaks. Each measurement was performed in
duplicate and averaged. The method was calibrated by a 2nd degree polynomial regression curve with
a coefficient of determination of 0.9969. The limit of quantification was determined to be 0.25 µg/mL.
2.5. Determination of Saturation Solubility
For the investigation of saturation solubility, nanocrystal suspension was diluted in Milli-Q-water
to a Symurban concentration of 1.0%. As reference, 1.0% Symurban raw drug powder was dispersed
in 0.4% aqueous Plantacare 810 UP solution to keep the surfactant concentration equal to the dilution
of nanocrystals. Both dilutions were then shaken for 24 h in an Innova 4230 shaker (New Brunswick
Scientific GmbH, Nürtingen, Germany) at 25 ◦C and 150 rpm. The undissolved Symurban crystals
were removed by filtration using a 25 mm Cellulose Nitrate syringe-filter with a cutoff of 0.1 µm
(GE Helathcare Life Sciences, Buckinghamshire, UK). Filtrates were diluted immediately 1:2 in aqueous
0.4% Plantacare 810 UP solution to avoid re-crystallization of supersaturated solution. Symurban
concentration was then measured by GC-MS, c.f. Section 2.4. The determination of saturation solubility
was done in triplicate. A Tuckey test was performed to determine significance (p < 0.01).
2.6. Skin Penetration Study
The skin penetration of Symurban nanocrystals was determined in a case study on one male
volunteer using the tape stripping method [40,41]. The volunteer obtained written information about
the purpose, extent, potential risks and the aim of the study. In addition, an informational conversation
was held in which the volunteer was able to ask open questions. His willingness to participate in
this study was confirmed by his signature, as well as the information that the willingness can be
countermanded at any time without any personal disadvantage. Symurban nanocrystal hydrogel at
0.25% was prepared using Carbopol 981 NF at 0.25% as gelling agent. On the inner forearm of the
volunteer, an area of 1.5 × 2 cm was treated with 45 mg of prepared hydrogel. After 20 min, the area
was tape stripped 30 times using tesafilm® Kristallklar (tesa SE, Norderstedt, Hamburg, Germany).
The Symurban removed by the adhesive tapes was extracted in 3.5 mL methyl tert-butyl ether and
the concentration in supernatant analyzed by GC-MS, c.f. Section 2.4. As a reference formulation,
a high-quality anti-pollution facial serum with 0.25% Symurban (measured by GC-MS) and comparable
viscosity to nanocrystal hydrogel was used.
3. Results and Discussion
3.1. Production Method of Symurban Nanocrystals
For the production of Symurban nanocrystals, the two commonly applied top-down methods,
high pressure homogenization and bead milling, were used. An aqueous Symurban suspension at 10%
was prepared and processed, stabilized by 2.0% Polysorbate 80 for stabilizing nanosized suspensions.
Unprocessed Symurban raw drug powder had a broad size distribution (0.4 to 800 µm) with a peak
maximum at 25 µm (Figure 2, red curve). Applying five cycles of high-pressure homogenization at
1500 bar considerably decreased both the width of distribution (0.4 to 40 µm) and the peak maximum to
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5.4µm. However, after 10 cycles, almost no change in size distribution and peak maximum was observed.
Even after a total of 15 homogenization cycles, the peak maximum decreased only marginally to
4.1 µm (Figure 2, light-blue curve) and the desired nm range was not reached. Therefore, high-pressure
homogenization was considered to be unsuited for the production of Symurban nanocrystals.
Figure 2. Laser diffraction (LD) particle size distribution of Symurban nanocrystals produced by
high-pressure homogenization (upper) and bead milling (lower), showing that only bead milling leads
to appropriate size reduction of Symurban µm-crystals.
Besides the high-pressure homogenization, bead milling was also examined for its suitability to
produce Symurban nanocrystals. Already after a milling time of 5 min, the peak maximum of the raw
drug powder curve at 25 µm shifted to 0.95 µm, being in the targeted nm-range. The particle size
distribution was still broad, with the presence of a second particle fraction with sizes of 10–200 µm.
This can be attributed to an unground fraction of the sample. After 20 min of milling, the second
fraction >10 µm completely disappeared and the peak maximum shifted to 268 nm. The increase of the
milling time to 30 min leads to a so-called “over-processing” of the suspension, visible in the further
broadening of the particle distribution from 0.04 to 7 µm (20 min) to 0.04–30 µm (30 min). A narrow
distribution is, however, essential for nanocrystal suspensions, as storage stability is considerably
higher than for broad-distributed suspensions whose small particles dissolve in favour of the large
particles (Ostwald ripening, [42]).
In conclusion, Symurban nanocrystals at 10% can be obtained by bead milling. Optimal milling
time was determined to be 20 min. Stabilized by Polysorbate 80 at 2.0% PCS, a z-ave of 295 nm with
polydispersity index of 0.32 was achieved. These values were in good agreement with LD diameters
LD50% of 0.26 µm, LD90% of 1.74 µm, and LD95% of 2.81 µm.
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3.2. Screening of Surfactants
A selection of 15 surfactants from different types (anionic, amphoteric, non-ionic-PEG,
non-ionic-polyglyceryl and non-ionic-glucoside) was used at 2.0% to stabilize 10.0% Symurban
nanocrystal suspensions. The majority of the surfactants tested are ECOCERT-certified and are
highlighted in green in Figure 3. In addition, four surfactants were tested, which are not
ECOCERT-certified but have excellent stabilizing properties. These surfactants are highlighted in red in
Figure 3. Directly after production, all suspensions were examined under the microscope. Respective
images are shown in Figure 3 with their corresponding LD50% values (Figure 3, left), zeta potentials
(Figure 3, middle) and PCS z-averages (Figure 3, right). Six of fifteen surfactants, i.e., Bergasoft SCG 22,
Eumulgin SG, Lanette E, Miranol Ultra C32, SDS and Sisterna SP70-C, showed a pronounced tendency
to form large aggregates visible to the naked eye already on the day of production. For these samples,
particle size and zeta potential were not determined (abbreviated as n.d. in Figure 3).
Figure 3. Microscopic images at 400-fold magnification (scale bar 50 µm) for all produced samples with
2% surfactant, where ECOCERT surfactants are highlighted green and non-ECOCERT surfactants in red.
The type of surfactant used is written above respective image, the z-average (z-ave) and polydispersity
index (PdI) left under the image, and LD50% value and zeta potential right under the image.
Clear tendencies could be identified in the surfactant screening. With anionic and amphoteric
surfactants, no stable Symurban nanocrystal suspension could be obtained, with all showing
a pronounced formation of aggregates. Furthermore, surfactants with high hydrophilic properties
indicated by high HLB values >20 proved to be unsuited for Symurban nanocrystal stabilization. Among
the three subtypes of non-ionic surfactants, PEG, polyglyceryl and glucoside, no correlation could be
found. In each of the three subtype groups, both representatives can be found, one with high stabilizing
properties in terms of particle size and size distribution and one showing pronounced aggregation
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(e.g., Plantacare 2000 UP led to aggregation whereas Plantacare 810 UP remained stable—both are
alkyl glucosides).
The four best-performing surfactants among the 15 surfactants tested in terms of appearance (no
aggregates), particle size (PCS mean particle size < 300 nm, LD50% < 300 nm), and size distribution (PdI
< 0.35) were identified as Dermofeel G10L, Plantacare 810 UP, Polyaldo 10-1-CC, and Sisterna L70-C.
3.3. Storage Stability of Symurban Nanocrystals
The four best formulations were stored in the refrigerator at 4 ◦C, at 25 ◦C and in the oven at 40 ◦C,
and their physical stability was re-analyzed after 1 month. After 1 month of storage of Dermofeel G10L
stabilized formulation at 25 ◦C, mean particle size and PdI clearly increased from 286 to 598 nm and
from 0.33 to 0.45 (Table 2). The LD90% value > 1.3 µm additionally confirmed that this formulation is
not storage-stable. Comparable observations were made for the Sisterna L70-C-stabilized formulation.
With a z-ave of 522 nm, PdI of 0.5 and LD90% > 4 µm at the same storage conditions, this formulation
was not stable.
Table 2. Particle size (PCS z-ave, LD D50, D90 and D95 all in [nm]) and polydispersity index (PdI)
of Symurban nanocrystals produced with 1.5% of the 4 best surfactants after 1 month storage at 4,
25, and 40 ◦C, showing that Plantacare 810 UP provides the highest physical storage stability. Values
exceeding the nm-range were written in red.
Surfactant 1 Month at 4 ◦C 1 Month at 25 ◦C 1 Month at 40 ◦C
z-ave PdI D50 D90 D95 z-ave PdI D50 D90 D95 z-ave PdI D50 D90 D95
Dermofeel G10L 307 0.30 252 799 1085 598 0.45 307 1332 1674 747 0.31 1175 3042 4368
Plantacare
810 UP 263 0.20 257 569 708 270 0.21 231 449 523 345 0.20 295 758 3342
Polyaldo
10-1-CC 286 0.20 249 622 815 357 0.24 315 1206 1988 532 0.28 428 3371 27,401
Sisterna
L70-C 263 0.34 268 2454 3243 522 0.50 2028 4353 5191 1589 0.58 2448 4767 5780
In contrast, Plantacare 810 UP and the Polyaldo 10-1-CC-stabilized formulation showed no
noticeable changes under the microscope after 1 month storage at 25 ◦C. Both z-ave and PdI remained
stable below 360 nm and 0.24, respectively. The only difference between the two was the LD95%
and LD99% values. A higher storage stability was observed for the Plantacare 810 UP sample with
an LD99% value of < 1 µm versus > 4 µm for the Polyaldo-10-1-CC sample. Furthermore, at the
two other storage temperatures of 4 and 40 ◦C, the Plantacare 810 UP formulation was superior
with smaller z-ave, PdI and LD99% values. Both are non-ionic surfactants sterically stabilizing the
particles in the suspension. However, in contrast to the Polyaldo-10-1-CC formulation, the Plantacare
810 UP formulation provides additional electrostatic stabilization based on the low zeta potential of
−49 mV. This may explain the higher storage stability of the Plantacare 810 UP formulation. For this
formulation, sufficient stability over 1 year was demonstrated at 25 ◦C, with a z-ave of 354 nm, a PdI
of 0.20 and an LD95% value of <1 µm (Figure 4). The formulation also showed sufficient stability at
4 ◦C storage. Under stress conditions of 40 ◦C, crystal growth was observed. This can be explained
by increased solubility and decreased viscosity of the formulation at higher temperatures, promoting
Ostwald ripening.
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Figure 4. Particle size and polydispersity index of Symurban nanocrystals stabilized with 2% Plantacare
810 UP after 12 months of storage at 4, 25 and 40 ◦C. Best stability was achieved at 25 ◦C followed by
4 ◦C. Under stress conditions of 40 ◦C, aggregation occurred.
In conclusion, Symurban nanocrystals at 10% stabilized with the ECOCERT-certified Plantacare
810 UP at 2.0% proved to be storage-stable for 1 year at both 4 and 25 ◦C.
Furthermore, the formulation proofed to be chemically stable. After 1 year of storage, no significant
reduction of Symurban concentration as nanocrystal suspensions was observed at any storage
temperature (4, 25 and 40 ◦C) with the minimum remaining Symurban content of >97.5 ± 0.21%.
All in all, the best formulation, consisting of 10% Symurban, 2% Plantacare 810 UP and 88%
Milli-Q water and produced by 20 min of wet bead milling, proved to be highly stable physically and
chemically. The recommended storage temperature was found to be 25 ◦C, but a storage at 4 ◦C also
proved to be feasible.
3.4. Saturation Solubility
The increased dermal bioavailability of active compounds by nanocrystal technology is achieved
through increased saturation solubility. Therefore, the extent of saturation solubility increase of
Symurban as nanocrystals is of interest. It was measured by GC (c.f. 2.4.) and compared to
unprocessed µm-sized raw drug powder in water and in 0.2% aqueous Plantacare 810 UP solution
(identical to the composition of nanocrystal suspension). Results of the saturation solubility study are
presented in Figure 5. The saturation solubility for the nanocrystal formulation is significantly increased
by a factor of >15 for raw drug powder in an aqueous surfactant solution and > 11 for raw drug powder
in water from 0.19 ± 0.05 µg/mL and 0.25 ± 0.02 µg/mL to 2.86 ± 0.45 µg/mL, respectively. As the
penetration of active compounds into skin is a passive diffusion process, it is mainly dependent on the
concentration gradient between the formulation and skin and therefore on the saturation concentration
of active compounds in the formulation [30,33,34]. By preparing Symurban as nanocrystals, a clearly
improved dermal bioavailability can therefore be expected.
Cosmetics 2020, 7, 17 10 of 13
Figure 5. Saturation solubility of Symurban as nanocrystals and raw drug powder (RDP) in water and
in aqueous surfactant solution according to the composition of nanocrystal suspension, demonstrating
at least an 11-fold increased saturation solubility by nanocrystal technology.
3.5. Skin Penetration Profile
The assumption of improved dermal bioavailability by increased saturation solubility was verified
in a case study on a male volunteer using the tape stripping method. Instead of using a hydrogel
with Symurban µm-crystals as a reference, the performance of nanocrystal hydrogel was compared to
a Symurban-containing market product of higher price level with an anti-pollution claim. The selection
of a product being already optimized for the market was intended to challenge the nanocrystals as
delivery system.
Both formulations had the same Symurban content of 0.25 wt%. Futhermore, the applied amount
of formulation and size of skin area were kept identical. After 20 min of penetration, each skin
area was taped 30 times and the content of Symurban in the tapes was determined via GC (c.f. 2.4.)
to create penetration profiles. The recovery rate of both formulations was comparable with 90.2%
(reference product) and 92.3% (smartCyrstals gel). The loss of <10% is attributable to the fact that
active ingredients penetrate not only vertically but also horizontally. The penetration depth exceeded
the depth reached by 30 tapes and could therefore not be determined and compared. Clear differences
can be seen in the distribution of the active ingredient in the skin (Figure 6). The penetration profile
of market product shows that 47% and therefore almost half of applied Symurban are located in the
first 2 tapes (Figure 6, grey bars). With 7% in the tapes 19-30, only a negligible amount reaches the
deeper layers. In contrast, the nanocrystal hydrogel allowed deeper penetration of larger amounts of
Symurban, which is reflected in the Symurban content of only 26% in the first two tapes and more than
twice as much in tapes 19-30 (Figure 6, yellow bars). Symurban nanocrystal hydrogel therefore shows
a more favorable distribution, with higher concentrations in the deeper layers of the stratum corneum.
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Figure 6. Penetration profiles measured on the inner forearm of one volunteer with healthy skin
conditions via a tape stripping test after 20 min application of Symurban nanocrystal hydrogel (yellow
bars) and a commercially available anti-pollution product (grey bars) with identical Symurban amount.
The present data confirm that by reducing the crystal size of Symurban into the submicron range,
its penetration can be improved. This result is consistent with data from literature showing superior
skin penetration of submicron particles compared to raw drug powder [30–34].
4. Conclusions
A Symurban nanocrystal suspension at 10 wt% with mean particle size of 280 nm and PdI of
0.27 was obtained by wet bead milling at 2000 rpm for 30 min. Generally, Symurban nanocrystals
were better stabilized by non-ionic surfactants compared to anionic surfactants. Highest physical and
chemical storage stability among the 15 screened surfactants was obtained with 2 wt% Plantacare
810 UP, a skin-friendly and organic-certified surfactant. No particle growth (z-ave of 354 nm and
PdI of 0.20) nor chemical degradation (>97%) was observed within 12 months at 4 ◦C and at room
temperature. By nanocrystal technology, an increase in saturation solubility by a factor of >11 was
obtained, leading to a favorable penetration profile with higher concentration of Symurban in deeper
skin layers demonstrated by a tape stripping test on the inner forearm of one volunteer. Thus,
nanocrystals can be seen as a highly promising system of poorly soluble Symurban to provide a more
effective protection of the skin from harmful environmental pollution.
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